{ "version": "2.2", "instance": { "tnon-20220607.htm cm097_ex99-1.htm": { "nsprefix": "tnon", "nsuri": "http://www.tenonmed.com/20220607", "dts": { "inline": { "local": [ "cm097_ex99-1.htm", "tnon-20220607.htm" ] }, "schema": { "local": [ "tnon-20220607.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] }, "calculationLink": { "local": [ "tnon-20220607_cal.xml" ] }, "definitionLink": { "local": [ "tnon-20220607_def.xml" ] }, "labelLink": { "local": [ "tnon-20220607_lab.xml" ] }, "presentationLink": { "local": [ "tnon-20220607_pre.xml" ] } }, "keyStandard": 80, "keyCustom": 2, "axisStandard": 2, "axisCustom": 0, "memberStandard": 1, "memberCustom": 2, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2021q4": 3 }, "contextCount": 10, "entityCount": 1, "segmentCount": 3, "elementCount": 105, "unitCount": 3, "baseTaxonomies": { "http://fasb.org/us-gaap/2021-01-31": 122, "http://xbrl.sec.gov/dei/2021q4": 23 }, "report": { "R1": { "role": "http://www.tenonmed.com/role/CoverPage", "longName": "1001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "P06_07_2022To06_07_2022", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "tnon-20220607.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P06_07_2022To06_07_2022", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "tnon-20220607.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited", "longName": "1002 - Statement - Interim Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)", "shortName": "Interim Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "P01_01_2022To03_31_2022", "name": "us-gaap:Revenues", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cm097_ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To03_31_2022", "name": "us-gaap:Revenues", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cm097_ex99-1.htm", "first": true, "unique": true } }, "R3": { "role": "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited", "longName": "1003 - Statement - Interim Condensed Consolidated Balance Sheets (Unaudited)", "shortName": "Interim Condensed Consolidated Balance Sheets (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "PAsOn03_31_2022", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cm097_ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn03_31_2022", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cm097_ex99-1.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical", "longName": "1004 - Statement - Interim Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "shortName": "Interim Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "PAsOn03_31_2022", "name": "us-gaap:DeferredFinanceCostsNet", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cm097_ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn03_31_2022", "name": "us-gaap:DeferredFinanceCostsNet", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cm097_ex99-1.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Accounts Payable, Current", "terseLabel": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r22", "r196" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r78", "r129", "r130", "r191" ] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r24" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 23.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive income (loss)", "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge." } } }, "auth_ref": [ "r30", "r31", "r32", "r79", "r180", "r187", "r188" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r15", "r152", "r196" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "AmendmentFlag", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "TOTAL ASSETS", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r61", "r69", "r93", "r117", "r120", "r124", "r131", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r156", "r160", "r165", "r196", "r215", "r216", "r220" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "AssetsAbstract", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Assets, Current", "totalLabel": "Total current assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r3", "r5", "r28", "r93", "r131", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r156", "r160", "r165", "r196", "r215", "r216", "r220" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r0", "r20", "r42" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "CityAreaCode", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "ClassOfStockDomain", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited", "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r93", "r106", "r107", "r109", "r110", "r112", "r113", "r131", "r135", "r137", "r138", "r139", "r142", "r143", "r144", "r145", "r146", "r147", "r165", "r189", "r206", "r208", "r212" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "CommonStockMember", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r210", "r211", "r218" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock par or stated value per share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r14" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r14" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r14" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r14", "r47" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.001 par value; 130,000,000 and 10,487,904 shares authorized at March 31, 2022 and December 31, 2021, respectively; 989,954 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r14", "r196" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Total comprehensive loss attributable to Tenon Medical, Inc.", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r33", "r82", "r84", "r91", "r177", "r182" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "negatedLabel": "Comprehensive loss attributable to non-controlling interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r51", "r52", "r56", "r82", "r84", "r90", "r176", "r181" ] }, "tnon_ConvertibleNotesPayableAndAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://www.tenonmed.com/20220607", "localname": "ConvertibleNotesPayableAndAccruedInterest", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable And Accrued Interest", "terseLabel": "Convertible notes payable and accrued interest \u2013 net of debt discount of $14 and $31 at March 31, 2022 and December 31, 2021, respectively", "documentation": "Convertible notes payable and accrued interest." } } }, "auth_ref": [] }, "tnon_ConvertibleNotesPayableAndAccruedInterestDueToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://www.tenonmed.com/20220607", "localname": "ConvertibleNotesPayableAndAccruedInterestDueToRelatedParties", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable And Accrued Interest Due To Related Parties", "terseLabel": "Convertible notes payable and accrued interest due to related parties \u2013 net of debt discount of $1 and $2 at March 31, 2022 and December 31, 2021, respectively", "documentation": "Convertible notes payable and accrued interest due to related parties." } } }, "auth_ref": [] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Cost of Revenue", "terseLabel": "Cost of sales", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r36", "r93", "r131", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r165", "r215" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Convertible notes payable and accrued interest due to related parties", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r57", "r59", "r217" ] }, "us-gaap_DeferredCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "DeferredCosts", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Deferred Costs, Noncurrent", "terseLabel": "Deferred offering costs", "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent." } } }, "auth_ref": [ "r9", "r60", "r68" ] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt Issuance Costs, Net", "terseLabel": "Convertible notes payable and accrued interest", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r21", "r58", "r217" ] }, "us-gaap_DepositsAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "DepositsAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Deposits Assets, Noncurrent", "terseLabel": "Deposits", "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r21" ] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "DocumentInformationTable", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "DocumentType", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasicAndDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "EarningsPerShareBasicAndDiluted", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "Net Loss Attributable to Tenon Medical, Inc. Per Share of Common Stock, Basic and diluted", "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r213" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r198" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r198" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r204" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "EntityFileNumber", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "EntityRegistrantName", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r198" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r198" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "EquityComponentDomain", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r47", "r76", "r85", "r86", "r87", "r94", "r95", "r96", "r98", "r103", "r105", "r111", "r132", "r148", "r149", "r150", "r151", "r153", "r154", "r163", "r166", "r167", "r168", "r169", "r170", "r171", "r183", "r184", "r185", "r190" ] }, "us-gaap_GainLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "GainLossOnInvestments", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_OtherExpenses", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Investments", "terseLabel": "Gain on investments", "documentation": "Amount of realized and unrealized gain (loss) on investment." } } }, "auth_ref": [ "r40", "r44", "r205" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "General and Administrative Expense", "terseLabel": "General and administrative expenses", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r37" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Gross Profit", "totalLabel": "Gross (Loss) Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r35", "r93", "r117", "r119", "r123", "r125", "r131", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r165", "r193", "r215" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_OtherExpenses", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Interest Expense", "negatedLabel": "Interest expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r58", "r66", "r88", "r116", "r172" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Inventory, Net", "terseLabel": "Inventory", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r1", "r27", "r196" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r23", "r93", "r131", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r157", "r160", "r161", "r165", "r192", "r215", "r220", "r221" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS' DEFICIT", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r19", "r62", "r71", "r196", "r209", "r214", "r219" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities, Convertible Preferred Stock, and Stockholders' Deficit" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current", "totalLabel": "Total current liabilities", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r25", "r93", "r131", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r157", "r160", "r161", "r165", "r196", "r215", "r220", "r221" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "LocalPhoneNumber", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net Loss Attributable to Tenon Medical, Inc.", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r34", "r41", "r65", "r73", "r77", "r81", "r83", "r87", "r93", "r97", "r99", "r100", "r101", "r102", "r104", "r105", "r108", "r117", "r119", "r123", "r125", "r131", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r164", "r165", "r193", "r215" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Loss attributable to non-controlling interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r53", "r55", "r81", "r83", "r104", "r105", "r207" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other Income (Expense)" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Operating Expenses", "totalLabel": "Total Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "OperatingExpensesAbstract", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating Expenses" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Operating Income (Loss)", "totalLabel": "Loss from Operations", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r117", "r119", "r123", "r125", "r193" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Current", "terseLabel": "Current portion of operating lease liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r174" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liability \u2013 net of current portion", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r174" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r173" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent", "totalLabel": "Total Comprehensive Loss", "documentation": "Amount before tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r50", "r51", "r54" ] }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax", "terseLabel": "Unrealized loss on investments", "documentation": "Amount, after tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method." } } }, "auth_ref": [ "r80", "r162" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Change in foreign currency translation adjustment", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r29" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]", "terseLabel": "Consolidated Statements of Comprehensive Loss:" } } }, "auth_ref": [] }, "us-gaap_OtherExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "OtherExpenses", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Other Expenses", "negatedTotalLabel": "Total Other Expense", "documentation": "Amount of expense classified as other." } } }, "auth_ref": [ "r38", "r74" ] }, "us-gaap_OtherGeneralExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "OtherGeneralExpense", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_OtherExpenses", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Other General Expense", "negatedLabel": "Other expense", "documentation": "Amount of general expenses not normally included in Other Operating Costs and Expenses." } } }, "auth_ref": [ "r39" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r200" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r201" ] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r2", "r4", "r133", "r134" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net Loss", "verboseLabel": "Net loss", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r77", "r81", "r83", "r92", "r93", "r97", "r104", "r105", "r117", "r119", "r123", "r125", "r131", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r155", "r158", "r159", "r164", "r165", "r178", "r193", "r194", "r195", "r207", "r215" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net", "terseLabel": "Fixed assets - net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r7", "r8", "r45", "r72", "r179", "r196" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Research and Development Expense", "terseLabel": "Research and development expenses", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r49", "r75", "r222" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit", "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit." } } }, "auth_ref": [ "r16", "r48", "r70", "r152", "r186", "r188", "r196" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "Revenues", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Revenues", "terseLabel": "Revenue", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r89", "r93", "r114", "r115", "r118", "r121", "r122", "r126", "r127", "r128", "r131", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r165", "r178", "r215" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "Security12bTitle", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r197" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "SecurityExchangeName", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r199" ] }, "us-gaap_SellingAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "SellingAndMarketingExpense", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing expenses", "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services." } } }, "auth_ref": [] }, "tnon_SeriesAConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.tenonmed.com/20220607", "localname": "SeriesAConvertiblePreferredStockMember", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited", "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Series A Convertible Preferred Stock [Member]", "documentation": "Series A convertible preferred stock." } } }, "auth_ref": [] }, "tnon_SeriesBConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.tenonmed.com/20220607", "localname": "SeriesBConvertiblePreferredStockMember", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited", "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Series B Convertible Preferred Stock [Member]", "documentation": "Series B convertible preferred stock." } } }, "auth_ref": [] }, "us-gaap_ShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "ShortTermInvestments", "crdr": "debit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Short-term Investments", "terseLabel": "Investments", "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current." } } }, "auth_ref": [ "r10", "r63", "r64", "r67" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "SolicitingMaterial", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r202" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited", "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r12", "r13", "r14", "r47", "r93", "r106", "r107", "r109", "r110", "r112", "r113", "r131", "r135", "r137", "r138", "r139", "r142", "r143", "r144", "r145", "r146", "r147", "r165", "r189", "r206", "r208", "r212" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r26", "r47", "r76", "r85", "r86", "r87", "r94", "r95", "r96", "r98", "r103", "r105", "r111", "r132", "r148", "r149", "r150", "r151", "r153", "r154", "r163", "r166", "r167", "r168", "r169", "r170", "r171", "r183", "r184", "r185", "r190" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "StatementLineItems", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited", "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "StatementTable", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited", "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r94", "r95", "r96", "r111", "r175" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total stockholders' deficit", "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity." } } }, "auth_ref": [ "r14", "r17", "r18", "r43", "r196", "r209", "r214", "r219" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders' Deficit" } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "TemporaryEquityAbstract", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Temporary Equity [Abstract]", "terseLabel": "Convertible Preferred Stock" } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "TemporaryEquityCarryingAmountAttributableToParent", "crdr": "credit", "calculation": { "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 24.0 } }, "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnaudited" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "terseLabel": "Convertible Preferred Stock", "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r135", "r137", "r138", "r139", "r142", "r143" ] }, "us-gaap_TemporaryEquityLiquidationPreference": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "TemporaryEquityLiquidationPreference", "crdr": "credit", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Liquidation Preference", "terseLabel": "Temporary equity liquidation preference", "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "TemporaryEquityParOrStatedValuePerShare", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Par or Stated Value Per Share", "terseLabel": "Temporary equity, par or stated value per share", "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable." } } }, "auth_ref": [ "r6", "r46" ] }, "us-gaap_TemporaryEquitySharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "TemporaryEquitySharesAuthorized", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Shares Authorized", "terseLabel": "Temporary equity shares authorized", "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r11" ] }, "us-gaap_TemporaryEquitySharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "TemporaryEquitySharesIssued", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Shares Issued", "terseLabel": "Temporary equity shares issued", "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r11" ] }, "us-gaap_TemporaryEquitySharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "TemporaryEquitySharesOutstanding", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedBalanceSheetsUnauditedParenthetical" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Shares Outstanding", "terseLabel": "Temporary equity shares outstanding", "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r11" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "TradingSymbol", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "presentation": [ "http://www.tenonmed.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "terseLabel": "Weighted-Average Shares of Common Stock Outstanding, Basic and diluted", "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS)." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "localname": "WrittenCommunications", "presentation": [ "http://www.tenonmed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r203" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "45", "Paragraph": "1", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "45", "Paragraph": "2", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "45", "Paragraph": "3", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(27)", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(2))", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27))", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.1)", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.17)", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.6(a))", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.9)", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "11", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2)", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4,6)", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.6)", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "28", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "320", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27405-111563" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "2", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "730", "SubTopic": "10", "Section": "50", "Paragraph": "1", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "19", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "20", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(4))", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(5))", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "220", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "220", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "220", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "220", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04.7)", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "105", "SubTopic": "10", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "50", "Paragraph": "7", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3))", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "10A", "Subparagraph": "(dd)", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "50", "Paragraph": "4", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "50", "Paragraph": "5", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "50", "Paragraph": "6", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "2", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "235", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "45", "Paragraph": "24", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "3", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "4", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "8", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "9", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "2", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "3", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "272", "SubTopic": "10", "Section": "45", "Paragraph": "1", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "272", "SubTopic": "10", "Section": "50", "Paragraph": "1", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "272", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "40", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "42", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Section": "45", "Paragraph": "2", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Section": "45", "Paragraph": "9", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "323", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "326", "SubTopic": "10", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "340", "SubTopic": "10", "Section": "05", "Paragraph": "5", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "340", "SubTopic": "10", "Section": "45", "Paragraph": "1", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "65", "Paragraph": "15", "Subparagraph": "(g)(2)", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "19", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(bb)", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "40", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "40", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "830", "SubTopic": "30", "Section": "45", "Paragraph": "17", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "830", "SubTopic": "30", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "830", "SubTopic": "30", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "830", "SubTopic": "30", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "830", "SubTopic": "30", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "830", "SubTopic": "30", "Section": "50", "Paragraph": "1", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "842", "SubTopic": "20", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "842", "SubTopic": "20", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "924", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "220", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "220", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "235", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "360", "Section": "50", "Paragraph": "1", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "220", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "220", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "40", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "40", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "40", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "40", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "40", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "40", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "SEC", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Publisher": "FASB", "Subparagraph": "(a)(3)(iii)(03)" }, "r191": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "45", "Paragraph": "1", "Subparagraph": "(c)", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r192": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r193": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r194": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r195": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r196": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "852", "SubTopic": "10", "Section": "55", "Paragraph": "10", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r197": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r198": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r199": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r201": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r202": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r203": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r204": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r205": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r206": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "272", "SubTopic": "10", "Section": "45", "Paragraph": "3", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r207": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "50", "Paragraph": "6", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r208": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "235", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r209": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "235", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r210": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r211": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "45", "Paragraph": "24", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r212": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r213": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "7", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r214": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "323", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r215": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r216": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r217": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r218": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "40", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r219": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r220": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "852", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r221": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "852", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r222": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "912", "SubTopic": "730", "Section": "25", "Paragraph": "1", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" } } }